No exposure limit is set for this compound.
On the basis of its low inhalation toxicity, a
TLV-TWA value of 8 mg/m3 (2 ppm) can be
safely ascribed.
物理描述:
N-butyl isocyanate appears as a clear, colorless liquid with a pungent odor. Very toxic by ingestion, and may also be toxic by skin absorption and inhalation. Vapors heavier than air. Less dense than water and insoluble in water. Produces toxic oxides of nitrogen during combustion.
颜色/状态:
Colorless liquid
溶解度:
In water, 1.4X10+3 mg/L at 25 °C (est)
蒸汽密度:
3.00 (Air= 1)
蒸汽压力:
1.76X10+1 mm Hg at 25 °C (est)
自燃温度:
425 °C
分解:
Energy of decomposition (in range 160 to 450 °C) measured as 0.55 kJ/g.
... Reactive isocyanates in general, can react with biological molecules containing amino, alcohol, or sulfhydryl groups, as well as with water. While hydrolysis in an aqueous environment, such as the lung, is theoretically possible, measurements show that alkyl isocyanates are relatively resistant (compared to arylisocyanates) to such hydrolysis.
来源:Hazardous Substances Data Bank (HSDB)
代谢
异氰酸酯...形成不稳定的谷胱甘肽结合物,它们可以从这些结合物中被释放出来。/异氰酸酯/
Isocyanates ... form labile glutathione conjugates from which they can be released. /Isocyanate/
Benomyl (a non-thio fungicide) inhibits hepatic mitochondrial low-Km aldehyde dehydrogenase (mALDH or ALDH2) in ip-treated mice by 50% (IC50) at 7.0 mg/kg, which is surprisingly the same potency range as that for several dithiocarbamate fungicides (and the related alcohol abuse drug disulfiram) and thiocarbamate herbicides previously known for their alcohol-sensitizing action. The mechanism by which benomyl inhibits mALDH was therefore examined, first by comparing the metabolism of benomyl with the aforementioned mono- and dithiocarbamates and second by evaluating the inhibitory potency of the benomyl metabolites. Benomyl in ip-treated mice is converted, via butyl isocyanate, S-(N-butylcarbamoyl)glutathione, and S-(N-butylcarbamoyl)cysteine, to S-methyl N-butylthiocarbamate (MBT), identified as a transient metabolite in liver. MBT is >10-fold more potent than benomyl or butyl isocyanate as an in vivo mALDH inhibitor and is also more potent than the intermediary S-(N-butylcarbamoyl) conjugates. Benomyl and MBT inhibit mouse hepatic mALDH in vitro with IC50s of 0.77 and 8.7 uM, respectively. The potency of MBT is greatly enhanced by fortification of the mitochondria with NADPH alone or plus microsomes giving IC50s of 0.50 and 0.23 uM, respectively. This activation of MBT is almost completely blocked by the cytochrome P450 inhibitor N-benzylimidazole but not by several other cytochrome P450 inactivators. MBT (probably following bioactivation) inhibits mALDH in vivo with an IC50 of 0.3 mg/kg. Two candidate activation products were synthesized for potency determinations. N-Hydroxy MBT (prepared via the trimethylsilyl derivative) was not detected as an MBT metabolite; its low potency also rules against N-hydroxylation as the activation process. MBT sulfoxide, from oxidation of MBT with magnesium monoperoxyphthalate in water, is one of the most potent inhibitors known for mALDH and yeast ALDH in vitro (IC50 0.08-0.09 uM). These findings are consistent with a six-step bioactivation of benomyl, via the metabolites above and N-butylthiocarbamic acid, with MBT as the penultimate and MBT sulfoxide as the ultimate inhibitor of mALDH.
The inhibition of yeast (Saccharomyces cerevesiae) metabolism by fungicidal chemicals was investigated. Glucose- or ethanol-dependent yeast respiration was measured with an oxygen electrode, and manometric determination of carbon dioxide release was used to measure fermentation. Both respiration and fermentation were inhibited more by benomyl than by identical molar concentrations of its breakdown product, carbendazim. Butyl isocyanate, another benomyl breakdown product, inhibited respiration more but inhibited fermentation less than the parent compound. Of the isocyanates tested, hexyl isocyanate was the most inhibitory towards both activities. Captan was more active and iprodione less active than benomyl. Because benomyl rapidly broke down to carbendazim when it was prepared in 80% ethanol, only 59% of the dissolved benomyl was intact when it was added to yeast to determine its effect on respiration or fermentation.
Cyanide is rapidly alsorbed through oral, inhalation, and dermal routes and distributed throughout the body. Cyanide is mainly metabolized into thiocyanate by either rhodanese or 3-mercaptopyruvate sulfur transferase. Cyanide metabolites are excreted in the urine. (L96)
IDENTIFICATION AND USE: N-Butyl isocyanate is a colorless flammable liquid, and It is soluble in water. It is used as a reagent in organic synthesis; used as intermediates in production of carbamate, and urea insecticides, and fungicides. It is also used in the production of sulfonyl urea antidiabetic drugs. HUMAN EXPOSURE AND TOXICITY: In female subjects exposed to N-butyl isocyanate there was an irritating effect to the mucous membranes and temporary lesions to the cardiac conduction system. Occupational exposure to N-butyl isocyanate may occur through inhalation, and dermal contact in the workplace where this chemical is used or manufactured. Butyl isocyanate is an irritant to the eyes of workers in an occupational setting. It is a strong irritant to to the skin. Individuals with a history of asthma, allergies or impaired lung function are at increased risk to the adverse effects of N-butyl isocyanate exposure. ANIMAL STUDIES: In a repeated exposure study, male rats were exposed by inhalation to N-Butyl isocyanate. No treatment related clinical signs were observed in the low dose groups. At the higher dose groups animals appeared unkempt, and exhibited labored breathing, reduced motility and an increased serous discharge from the nose. Substantial decrease in pulmonary function was noted in high dose treated animals. High dose animals exhibited widespread septal destruction, indicative of emphysema. In male rats, exposed to N-butyl isocyanate, neutrophils, LDH, and protein in the bronchoalveolar lavage fluid were elevated. Lung function parameters were decreased. This chemical was a sensitizer in guinea pigs exposed by inhalation. No irritation was observed in a rabbit ear exposed to a solution of N-butyl isocyanate. Butyl isocyanate was highly corrosive to rabbit eyes when instillation of test material to the conjunctival sac. Cats exposed to this chemical orally, had no related clinical effects in hematology or methemoglobin formation. Butyl isocyanate was negative in an Ames test using Salmonella typhimurium strains TA 98, TA 100, TA 1535 and TA 1537 with and without metabolic activation.
Cyanide is an inhibitor of cytochrome c oxidase in the fourth complex of the electron transport chain (found in the membrane of the mitochondria of eukaryotic cells). It complexes with the ferric iron atom in this enzyme. The binding of cyanide to this cytochrome prevents transport of electrons from cytochrome c oxidase to oxygen. As a result, the electron transport chain is disrupted and the cell can no longer aerobically produce ATP for energy. Tissues that mainly depend on aerobic respiration, such as the central nervous system and the heart, are particularly affected. Cyanide is also known produce some of its toxic effects by binding to catalase, glutathione peroxidase, methemoglobin, hydroxocobalamin, phosphatase, tyrosinase, ascorbic acid oxidase, xanthine oxidase, succinic dehydrogenase, and Cu/Zn superoxide dismutase. Cyanide binds to the ferric ion of methemoglobin to form inactive cyanmethemoglobin. (L97)
来源:Toxin and Toxin Target Database (T3DB)
毒理性
致癌物分类
对人类不具有致癌性(未被国际癌症研究机构IARC列名)。
No indication of carcinogenicity to humans (not listed by IARC).
Exposure to high levels of cyanide for a short time harms the brain and heart and can even cause coma, seizures, apnea, cardiac arrest and death. Chronic inhalation of cyanide causes breathing difficulties, chest pain, vomiting, blood changes, headaches, and enlargement of the thyroid gland. Skin contact with cyanide salts can irritate and produce sores. (L96, L97)
来源:Toxin and Toxin Target Database (T3DB)
毒理性
暴露途径
所有暴露途径均可能引起严重的局部影响。
Serious local effects by all routes of exposure.
来源:ILO-WHO International Chemical Safety Cards (ICSCs)
Synthesis of Thiocarbamates from Thiols and Isocyanates Under Catalyst- and Solvent-Free Conditions
作者:Barahman Movassagh、Mohammad Soleiman-Beigi
DOI:10.1007/s00706-007-0762-7
日期:2008.2
A simple and efficient procedure was developed for the synthesis of S -alkyl (aryl) thiocarbamates under solvent-free conditions without the use of a catalyst. The significant features of this protocol are (a) operational simplicity, (b) mild reaction conditions, (c) short reaction times, (d) solvent-free conditions, and (e) high product yields.
Squaraines as Fluoro−Chromogenic Probes for Thiol-Containing Compounds and Their Application to the Detection of Biorelevant Thiols
作者:Jose V. Ros-Lis、Beatriz García、Diego Jiménez、Ramón Martínez-Máñez、Félix Sancenón、Juan Soto、Fernando Gonzalvo、M. Carmen Valldecabres
DOI:10.1021/ja031987i
日期:2004.4.1
A highlyselective colorimetric chemodosimeter for thiol-containing compounds in aqueous solutions is reported. The design protocol makes use of a highly specific reaction between thiols and the electrophilic four-membered ring of highly colored, fluorescent squaraine backbones. At neutral pH selective decoloration and total emission quenching was found due to the rupture of the highly delocalized
[EN] PYRAZOLOPYRIMIDINES AS CYCLIN-DEPENDENT KINASE INHIBITORS<br/>[FR] PYRAZOLOPYRIMIDINES TENANT LIEU D'INHIBITEURS DE KINASES DEPENDANTES DE LA CYCLINE
申请人:SCHERING CORP
公开号:WO2004022561A1
公开(公告)日:2004-03-18
In its many embodiments, the present invention provides a novel class of pyrazolo[1,5-a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.
Synthesis and biological evaluation of (3/4-(pyrimidin-2-ylamino)benzoyl)-based hydrazine-1-carboxamide/carbothioamide derivatives as novel RXRα antagonists
the expression and biological function of retinoid X receptor alpha (RXRα) have a key role in the development of cancer. Potential modulators of RXRα as anticancer agents are explored in growing numbers of studies. A series of (4/3-(pyrimidin-2-ylamino)benzoyl)hydrazine-1-carboxamide/carbothioamide derivatives are synthesised and evaluated for anticancer activity as RXRα antagonists in this study. Among